Addendum to: Koeberle PD, Wang Y, Schlichter LC. K V 1.1 and K V 1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Differ 2010; 17:134-44; PMID: 19696788; DOI: 10.1038 DOI: 10. / cdd.2009.113.Key words: neurotrauma, axotomy, optic nerve transection, microglial activation, apoptosis, K V 1.1, K V 1.3, siRNA in vivo, agitoxin-2, margatoxin Abbreviations: RGC, retinal ganglion cell; GCL, ganglion cell layer; NFL, nerve fiber layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer nuclear layer; CNS, central nervous system; BDNF, brain derived neurotrophic factor; CNTF, ciliary neurotrophic factor; GDNF, glial-cell line derived neurotrophic factor; NGF, nerve growth factor; bFGF, basic fibroblast growth factor; IGF, insulin-like growth factor; EGF, epidermal growth factor; NRTN, neurturin; iNOS, inducible nitric oxide synthase; IL-1β, interleukin-1-beta; IL-1ra, interleukin-1 receptor antagonist; TNFα, tumor necrosis factor-alpha; TGFβ, transforming growth factor-beta; CR3, complement receptor 3; MHC Class II, major histocompatibility complex class 2; GFAP, glial fibrillary acidic protein; HPRT-1, hypoxanthine phosphoribosyltransferase 1; AgTx-2, agitoxin-2; MgTx, margatoxin; α-DTX, alpha-dendrotoxin; K V , voltage gated potassium channel subunit; K V 1.1, voltage gated potassium channel family 1 member 1; K V 1.2, voltage gated potassium channel family 1 member 2; K V 1.3, voltage gated potassium channel family 1 member 3; Caspase-3, cysteine-aspartic protease-3; Caspase-9, cysteine-aspartic protease-9; Bad, Bcl-2-associated death promoter; Bclx L , B-cell lymphoma-extra large Numerous experimental studies have focused on identifying drug targets to rescue these neurons. We recently showed that K V 1.1 and K V 1.3 channels are expressed in adult rat RGCs and that siRNA-mediated knockdown of either channel reduces RGC death after optic nerve transection. Earlier we found that K V 1.3 channels also contribute to microglial activation and neurotoxicity; raising the possibility that these channels contribute to neurodegeneration through direct roles in RGCs and through inflammatory mechanisms. Here, RGC survival was increased by combined siRNA-mediated knockdown of K V 1.1 and K V 1.3 in RGCs, but survival was much greater when knockdown of either channel was combined with intraocular injection of a K V 1.3 channel blocker (agitoxin-2 or margatoxin). After axotomy, increased expression of several inflammation-related molecules preceded RGC loss and, consistent with a dual mechanism, their expression was differentially affected when channel knockdown in RGCs was combined with K V 1.3 blocker injection. K V 1.3 blockers reduced activation of retinal microglia and their tight apposition along RGC axon fascicles after axotomy, but did not prevent their migration from the inner plexiform to the damaged ganglion cell layer. Expression of several growth factors increased after axotomy; and again, there were differences following blocker